CytRx Corp. buy melinda
Start price
31.07.16
/
50%
€3.49
Target price
31.01.17
€8.12
Performance (%)
-35.75%
End price
31.01.17
€2.24
Summary
This prediction ended on 31.01.17 with a price of €2.24. Massive losses of -35.75% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% | 49.858% |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% | 100.330% |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% | 65.355% |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% | 68.657% |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
(Laufzeit überschritten)